Table 1 Clinicopathological characteristics and TRIM6 expression (n = 90)
From: TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1
Characteristic | Cases | % |
|---|---|---|
Gender | ||
Male | 48 | 53.3 |
Female | 42 | 46.7 |
Age (years) | ||
≥ 65 | 29 | 32.2 |
< 65 | 61 | 67.8 |
Tumor size (cm) | ||
≥ 4.0 | 60 | 66.7 |
< 4.0 | 30 | 33.3 |
Pathologic differentiation | ||
Well/Moderate | 75 | 83.3 |
Poor | 15 | 16.7 |
Clinical stage | ||
I/II | 43 | 47.8 |
III | 47 | 52.2 |
Metastasis | ||
yes | 17 | 18.9 |
no | 63 | 81.1 |
Vital status (at followed-up) | ||
Alive | 42 | 46.7 |
Dead | 48 | 53.3 |
CEA levels (ng/mL) | ||
≥ 3.5 | 58 | 64.4 |
< 3.5 | 32 | 35.6 |
TRIM24 expression | ||
Low | 34 | 37.8 |
High | 56 | 62.2 |